Drug Patent Expirations for Jul 13, 2017
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them
Click the patents below for more details, or visit DrugPatentWatch.com for more options.
| METOZOLV ODT (metoclopramide hydrochloride) | |
| Salix Pharms | |
| Patent number: | 6,413,549 |
| Expiration Date: | Jul 11, 2017 |
| TYKERB (lapatinib ditosylate) | |
| Novartis Pharms Corp | |
| Patent number: | 6,391,874 |
| Expiration Date: | Jul 11, 2017 |
| TYKERB (lapatinib ditosylate) | |
| Novartis Pharms Corp | |
| Patent number: | 6,828,320 |
| Expiration Date: | Jul 11, 2017 |
| EXCEDRIN (MIGRAINE) (acetaminophen; aspirin; caffeine) | |
| Glaxosmithkline Cons | |
| Patent number: | 5,972,916 |
| Expiration Date: | Jul 14, 2017 |
DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.
For more information try a trial
Comments are closed.